The prognostic value of B-catenin, CD10 and p63 Immunohistochemical expression in urothelial carcinoma

被引:0
|
作者
Hasan, Abdulkarim [1 ]
Elhawary, Reda [1 ]
Omar, Nasser [1 ]
Mandour, Esam [2 ]
机构
[1] Al Azhar Univ, Fac Med, Dept Pathol, Cairo 11884, Egypt
[2] Al Azhar Univ, Fac Med, Dept Pathol, Dumyat, Egypt
关键词
immunohistochemistry; prognosis; urothelial carcinoma; TRANSITIONAL-CELL CARCINOMA; BETA-CATENIN; E-CADHERIN; BLADDER; PROGRESSION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Detection of high-grade urothelial carcinoma is important for modification of therapy and improving the prognosis. We studied the prognostic value of beta-catenin, CD10 and p63 immunohistochemical expression in urothelial carcinoma and correlated this expression with the tumor grade and stage to evaluate the prognostic value of those commonly used markers. Material and Methods: Eighty four cases of urinary bladder urothelial carcinoma were obtained from the pathology archive and reexamined histologically for diagnosis, grading and staging then stained with beta-catenin, CD10, and p63 immunohistochemistry and evaluated. Results: Thirty cases were non invasive carcinomas and fifty four cases were invasive carcinomas. There was a significant relationship between beta-catenin positivity and higher tumor stage and higher tumor grade. CD10 expression showed significant correlation with tumor grade ( p=0.006) and tumor invasion. Also P63 antibody immunostaining expression revealed a significant correlation with tumor grade and tumor invasion. Conclusion: beta-catenin, CD10 and p63 expression can be used as a prognostic factor for high grade invasive urothelial carcinoma.
引用
收藏
页码:3362 / 3369
页数:8
相关论文
共 50 条
  • [1] CD10 expression in urothelial tumors: Comparison with K903 and P63
    Tismenetsky, M
    Amplianides, I
    Burstein, DE
    Miller, L
    Gan, L
    Legman, MD
    Unger, PD
    [J]. LABORATORY INVESTIGATION, 2005, 85 : 167A - 167A
  • [2] CD10 expression in urothelial tumors: Comparison with K903 and P63
    Tismenetsky, M
    Amplianides, I
    Burstein, DE
    Miller, L
    Gan, L
    Legman, MD
    Unger, PD
    [J]. MODERN PATHOLOGY, 2005, 18 : 167A - 167A
  • [3] CD10 expression in urothelial carcinoma of the bladder
    Burak Bahadir
    Kemal Behzatoglu
    Sibel Bektas
    Erol R Bozkurt
    Sukru O Ozdamar
    [J]. Diagnostic Pathology, 4
  • [4] CD10 expression in urothelial carcinoma of the bladder
    Bahadir, Burak
    Behzatoglu, Kemal
    Bektas, Sibel
    Bozkurt, Erol R.
    Ozdamar, Sukru O.
    [J]. DIAGNOSTIC PATHOLOGY, 2009, 4
  • [5] Immunohistochemical expression of P63, GLUT1 and XIAP in micropapillary urothelial carcinoma
    Idrees, MT
    Kafanas, A
    Gan, L
    Huan, Y
    Burstein, DE
    Unger, PD
    [J]. LABORATORY INVESTIGATION, 2006, 86 : 142A - 143A
  • [6] Comparitive immunohistochemical analysis of P63, SMA, CD10 and calponin in distinguishing insitu from invasive breast carcinoma
    Abdallah, D.
    Eldeeb, N.
    [J]. VIRCHOWS ARCHIV, 2014, 465 : S88 - S88
  • [7] Immunohistochemical expression of p63, GLUT1 and XIAP in micropapillary urothelial carcinoma
    Idrees, MT
    Kafanas, A
    Gan, L
    Huan, Y
    Burstein, DE
    Unger, PD
    [J]. MODERN PATHOLOGY, 2006, 19 : 142A - 143A
  • [8] Prognostic value of stromal CD10 expression in invasive breast carcinoma
    Ayadi, R.
    Bacha, D.
    Belkacem, O.
    Yaiche, R.
    Ben Amor, A.
    Gharbi, S.
    Ben Slama, S.
    Lahmar, A.
    Bouraoui, S.
    [J]. VIRCHOWS ARCHIV, 2019, 475 : S65 - S65
  • [9] CD10 and p63 expression in a sarcomatoid undifferentiated melanoma: A cautionary (and molecularly annotated) tale
    Lefferts, Joel A.
    Loehrer, Andrew P.
    Yan, Shaofeng
    Green, Donald C.
    Deharvengt, Sophie J.
    LeBlanc, Robert E.
    [J]. JOURNAL OF CUTANEOUS PATHOLOGY, 2020, 47 (06) : 541 - 547
  • [10] Expression Profile of CD10, BCL-2, p63, and EMA in the Normal Skin and Basal Cell Carcinomas: An Immunohistochemical Reappraisal
    Hussein, M. R.
    Ahmed, A. M.
    [J]. ACTAS DERMO-SIFILIOGRAFICAS, 2022, 113 (09): : T848 - T855